Teva Pharmaceutical Industries Ltd SEC filings TEVA

Teva Pharmaceutical Industries Ltd has 1,001 filings in SEC EDGAR's recent list, going back to Oct 17, 2017. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Teva Pharmaceutical Industries Ltd SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 5, 2026 —
144 Notice of proposed sale Nov 4, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 2, 2026 —
3 Initial insider ownership Oct 8, 2026 Sep 29, 2026
4 Insider transaction Sep 22, 2026 Sep 18, 2026
4 Insider transaction Sep 22, 2026 Sep 19, 2026
144 Notice of proposed sale Sep 21, 2026 —
144 Notice of proposed sale Sep 18, 2026 —
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 17, 2026 —
4 Insider transaction Aug 10, 2026 Aug 5, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
4 Insider transaction Jun 22, 2026 Jun 18, 2026
144 Notice of proposed sale Jun 18, 2026 —
4 Insider transaction Jun 16, 2026 Jun 11, 2026
144 Notice of proposed sale Jun 11, 2026 —
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
144 Notice of proposed sale Jun 5, 2026 —
4 Insider transaction Jun 4, 2026 Jun 3, 2026
144 Notice of proposed sale Jun 3, 2026 —
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction Jun 1, 2026 May 28, 2026
4 Insider transaction May 18, 2026 May 14, 2026
4 Insider transaction May 18, 2026 May 14, 2026
144 Notice of proposed sale May 14, 2026 —
144 Notice of proposed sale May 14, 2026 —
4 Insider transaction May 7, 2026 May 6, 2026
4 Insider transaction May 7, 2026 May 5, 2026
144 Notice of proposed sale May 5, 2026 —
4 Insider transaction May 4, 2026 May 1, 2026
4 Insider transaction May 4, 2026 Apr 30, 2026
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale Apr 30, 2026 —
4 Insider transaction Mar 19, 2026 Mar 17, 2026
144 Notice of proposed sale Mar 17, 2026 —
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
144 Notice of proposed sale Mar 5, 2026 —
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 4, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 3, 2026 —
4 Insider transaction Mar 2, 2026 Feb 26, 2026
144 Notice of proposed sale Feb 26, 2026 —
3 Initial insider ownership Feb 23, 2026 Feb 11, 2026
4 Insider transaction Feb 18, 2026 Feb 15, 2026
144/A Filing Feb 18, 2026 —
144 Notice of proposed sale Feb 18, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 9, 2026 —
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Jan 29, 2026 Jan 27, 2026
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 12, 2025 —
4 Insider transaction Dec 11, 2025 Dec 9, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
144 Notice of proposed sale Dec 9, 2025 —
144 Notice of proposed sale Dec 9, 2025 —
4 Insider transaction Dec 4, 2025 Dec 2, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
144 Notice of proposed sale Nov 26, 2025 —
4 Insider transaction Nov 24, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 20, 2025 —
4 Insider transaction Nov 18, 2025 Nov 14, 2025
144 Notice of proposed sale Nov 14, 2025 —
4 Insider transaction Nov 10, 2025 Nov 6, 2025
4 Insider transaction Nov 10, 2025 Nov 6, 2025
144/A Filing Nov 6, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Oct 6, 2025 —
144 Notice of proposed sale Sep 12, 2025 —
4 Insider transaction Sep 9, 2025 Sep 5, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
144 Notice of proposed sale Aug 1, 2025 —
144 Notice of proposed sale Aug 1, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 22, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jul 17, 2025 —
4 Insider transaction Jun 16, 2025 Jun 12, 2025
144 Notice of proposed sale Jun 12, 2025 —
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 9, 2025 Jun 5, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
144 Notice of proposed sale Jun 3, 2025 —
4 Insider transaction May 19, 2025 May 14, 2025
4 Insider transaction May 12, 2025 May 8, 2025
144 Notice of proposed sale May 8, 2025 —
3 Initial insider ownership Apr 7, 2025 Mar 31, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 7, 2025 Mar 5, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
144 Notice of proposed sale Mar 5, 2025 —
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144/A Filing Mar 4, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
4 Insider transaction Mar 4, 2025 Feb 28, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Feb 28, 2025 —
4 Insider transaction Feb 19, 2025 Feb 15, 2025
144 Notice of proposed sale Feb 18, 2025 —
4 Insider transaction Feb 14, 2025 Feb 12, 2025
144 Notice of proposed sale Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TEVA (NYSE)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Tel Aviv
SEC filer status
Large accelerated filer
SEC CIK
818686
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (until Jan 16, 2001)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.